These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1336854)

  • 1. [Effect of opioid receptor blockade with naloxone on vasopressin secretion in patients with transplanted kidney].
    Grzeszczak W; Zukowska-Szczechowska E; Kokot F
    Pol Arch Med Wewn; 1992 Oct; 88(4):219-24. PubMed ID: 1336854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of blockade of opiate receptors by naloxone on lutropin (LH), follitropin (FSH) and testosterone secretion in patients after kidney transplantation].
    Grzeszczak W; Zukowska-Szczechowska E; Kokot F
    Pol Arch Med Wewn; 1992; 87(4-5):250-7. PubMed ID: 1326100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of opioid receptor blockade with naloxone on secretion of atrial natriuretic peptide (ANP) in patients with kidney transplantation].
    Grzeszczak W; Zukowska-Szczechowska E; Kokot F
    Pol Arch Med Wewn; 1994 Mar; 91(3):177-83. PubMed ID: 8029124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of opioid receptor blockade with naloxone on plasma renin activity and aldosterone levels in patients with kidney transplantation].
    Zukowska-Szczechowska E; Grzeszczak W; Kokot F
    Pol Arch Med Wewn; 1992 Nov; 88(5):324-9. PubMed ID: 1300552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do opioid receptors participate in the regulation of atrial natriuretic peptide (ANP) secretion in hypertensive patients?
    Widera W; Kokot F; Wiecek A
    Clin Nephrol; 1992 Oct; 38(4):209-13. PubMed ID: 1330391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of naloxone on vasopressin secretion in conscious rats: evidence for inhibitory role of endogenous opioid peptides in vasopressin secretion.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Shiono S
    Endocrinology; 1989 Aug; 125(2):785-90. PubMed ID: 2546748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid-mediated inhibition of oxytocin during insulin-induced hypoglycemic stimulation of vasopressin in man.
    Seckl JR; Haddock JA; Dunne MJ; Lightman SL
    Acta Endocrinol (Copenh); 1988 May; 118(1):77-81. PubMed ID: 2838996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure and vasopressin in progressive autonomic failure. Response to postural stimulation, L-dopa and naloxone.
    Puritz R; Lightman SL; Wilcox CS; Forsling M; Bannister R
    Brain; 1983 Jun; 106 (Pt 2)():503-11. PubMed ID: 6850280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men.
    Coiro V; Capretti L; Speroni G; Castelli A; Bianconi L; Cavazzini U; Marcato A; Volpi R; Chiodera P
    J Endocrinol Invest; 1990 Oct; 13(9):757-63. PubMed ID: 2292659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The luteinizing hormone but not the cortisol response to arginine vasopressin is prevented by naloxone and a corticotropin-releasing hormone antagonist in the ovariectomized rhesus monkey.
    Xiao E; Xia-Zhang L; Thornell D; Shalts E; Ferin M
    Neuroendocrinology; 1996 Sep; 64(3):225-32. PubMed ID: 8875440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man.
    Coiro V; Chiodera P
    Neuroendocrinology; 1991 Mar; 53(3):209-13. PubMed ID: 2041583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of ethanol on the arginine vasopressin response to insulin-induced hypoglycemia and the role of endogenous opioids.
    Chiodera P; Coiro V
    Neuroendocrinology; 1990 May; 51(5):501-4. PubMed ID: 2112727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
    Alexander SL; Irvine CH
    Endocrinology; 1995 Nov; 136(11):5139-47. PubMed ID: 7588252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma levels of adrenaline and noradrenaline, plasma renin activity and arterial blood pressure in patients after kidney transplantation].
    Zukowska-Szczechowska E; Kokot F; Grzeszczak W; Wocial B
    Pol Arch Med Wewn; 1991 Oct; 86(4):254-62. PubMed ID: 1813878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of endogenous opioid peptides in the inhibition of arginine vasopressin release by gamma-aminobutyric acid in conscious rats.
    Otake K; Kondo K; Oiso Y
    Neuroendocrinology; 1991 Aug; 54(2):170-4. PubMed ID: 1766553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volume-regulated arginine vasopressin release in conscious dogs. Evidence for dopaminergic or opioid modulation?
    Hellebrekers LJ; Lagerweij E; de Vries HW; van Wimersma Greidanus TB
    Acta Endocrinol (Copenh); 1988 Sep; 119(1):106-12. PubMed ID: 2842992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of naloxone on corticotropin (ACTH) and somatotropin (HGH) secretion in patients with chronic renal failure].
    Grzeszczak W; Kokot F; Duława J
    Pol Arch Med Wewn; 1985 Sep; 74(3):181-8. PubMed ID: 2853865
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of naloxone on vasopressin level in the blood of patients with acute and chronic renal failure].
    Grzeszczak W; Kokot F; Duława J; Kuska J
    Pol Arch Med Wewn; 1985 Sep; 74(3):176-80. PubMed ID: 2853864
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure of naloxone to reverse apomorphine effects in humans.
    Rowbotham MC; Joseph MS; Jones RT; Keil LC
    Psychoneuroendocrinology; 1983; 8(1):95-102. PubMed ID: 6308702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Study on the mechanism of U50488H-induced diuresis.
    Oiso Y; Iwasaki Y; Kondo K; Takatsuki K; Tomita A
    Neuroendocrinology; 1988 Dec; 48(6):658-62. PubMed ID: 3251164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.